Amgen Inc. (AMGN)
NASDAQ: AMGN
· Real-Time Price · USD
292.57
-3.90 (-1.32%)
At close: Aug 18, 2025, 3:59 PM
292.01
-0.19%
After-hours: Aug 18, 2025, 05:39 PM EDT
Repatha (evolocumab) Revenue
History
| Quarter | Value | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.22B | 1.77B | +395.98% |
| Dec 31, 2023 | 448M | n/a | n/a |
| Dec 31, 2022 | n/a | n/a | n/a |
| Dec 31, 2021 | n/a | n/a | n/a |
| Dec 31, 2020 | n/a | n/a | n/a |
| Dec 31, 2019 | n/a | n/a | n/a |
| Dec 31, 2018 | n/a | n/a | n/a |
| Dec 31, 2017 | n/a | n/a | n/a |
| Dec 31, 2016 | n/a | n/a | n/a |
| Dec 31, 2015 | n/a | n/a | n/a |
| Dec 31, 2014 | n/a | n/a | n/a |
| Dec 31, 2013 | n/a | n/a | n/a |
| Dec 31, 2012 | n/a | n/a | n/a |